Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|5|369-374

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.5, 2008-05, pp. : 369-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2095-2103

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1341-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of Stat3 Signaling Pathway

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-01 ,pp. : 91-107

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3 Kinase Signaling Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 157-164

Bentham Science Publishers

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite